Jeffrey Siegel

Company: US Food & Drug Administration (FDA)

Job title: Office Director

Seminars:

Regulatory Considerations for Fluid & Imaging Biomarkers of Neurodegeneration & Neuroinflammation 8:45 am

Outline the different types of biomarkers using the BEST classification and their application in clinical trials Considerations for analytic and clinical validation of biomarkers Considerations for use of biomarkers as surrogate endpointsRead more

day: Conference Day One